Evidence map›Paper›PMID 42484658›Full record

ArticleDermatologie (Heidelberg, Germany)2026

[Cutaneous side effects of biologics: an important topic also in occupational dermatology].

Angel Peev, Maurice Waitek, Tatevik Martirosyan, Petra Roll, Elke Weisshaar

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Angel PeevSektion Berufsdermatologie, Zentrum Hautklinik, Universitätsklinikum Heidelberg, Ruprecht-Karls Universität Heidelberg, Voßstr. 2, 69115, Heidelberg, Deutschland.
Maurice WaitekSektion Berufsdermatologie, Zentrum Hautklinik, Universitätsklinikum Heidelberg, Ruprecht-Karls Universität Heidelberg, Voßstr. 2, 69115, Heidelberg, Deutschland.
Tatevik MartirosyanSektion Berufsdermatologie, Zentrum Hautklinik, Universitätsklinikum Heidelberg, Ruprecht-Karls Universität Heidelberg, Voßstr. 2, 69115, Heidelberg, Deutschland.
Petra RollPraxis für Rheumatologie Ulm, Ulm, Deutschland.
Elke WeisshaarSektion Berufsdermatologie, Zentrum Hautklinik, Universitätsklinikum Heidelberg, Ruprecht-Karls Universität Heidelberg, Voßstr. 2, 69115, Heidelberg, Deutschland. elke.weisshaar@med.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 42-year-old machinist suffered from ankylosing spondylitis since 2009. This had been treated with adalimumab 40 mg subcutaneous (s.c.) every two weeks since 2021. Approximately four years later, he developed erythema and pustules on his palms and soles of the feet. Palmoplantar pustular psoriasis and psoriasis vulgaris were diagnosed. His treatment was changed to secukinumab 150 mg s.c. every four weeks and his skin condition improved slightly. This case demonstrates the importance of considering adverse reactions to biologics in refractory palmoplantar psoriasis, even after years of treatment.

Indexed as

Ankylosing spondylitisHand eczemaPsoriasisSystemic therapyTNF‑α inhibitor

Identifiers

PMID42484658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.